Heritability heightens brain metabolite differences in schizophrenia

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 12, Issue 1, 2000, Pages 95-97

  Fukuzako, Hiroshi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIPERIDEN; CHLORPROMAZINE; CREATINE; CREATINE PHOSPHATE; EMONAPRIDE; HALOPERIDOL; N ACETYLASPARTIC ACID; PERICIAZINE; PERPHENAZINE; TRIHEXYPHENIDYL;

ADULT; ARTICLE; BRAIN METABOLISM; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE; FAMILY HISTORY; FEMALE; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA; TEMPORAL LOBE;

EID: 0033950729     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.12.1.95     Document Type: Article

References (16)

1. Keshavan MS, Montrose DM, Pierri JN, et al: Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: preliminary studies. Prog Neuropsychopharmacol Biol Psychiatry 1997; 21:1285-1295
2. Callicott JH, Egan MF, Bertolino A, et al: Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype. Biol Psychiatry 1998; 44:941-950
3. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biol Psychiatry 1994; 35:792-800
4. Kendler KS, Gruenberg AM, Tsuang MT: Psychiatric illness in first-degree relatives of schizophrenic and surgical control patients: a family study using DSM-III criteria. Arch Gen Psychiatry 1985; 42:770-779
5. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised. Washington, DC, American Psychiatric Association, 1987
6. Inagaki A, Yagi G: Treatment-resistant schizophrenia (in Japanese). Seishinigaku 1997; 39:684-695
7. Oldfield RC: The assessment and analysis of handedness: the Edinburgh Inventory. Neuropsychologia 1971; 9:97-113
8. Schachter SC, Ransil BJ, Geschwind N: Associations of handedness with hair color and learning disabilities. Neuropsychologia 1987; 25:269-276
9. Endicott J, Andreasen N, Spitzer RL: Family History Research Diagnostic Criteria. New York, New York State Psychiatric Institute, 1975
10. Fukuzako H, Takeuchi K, Hokazono Y, et al: Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report. Psychiatry Res (Neuroimaging) 1995; 61:193-200
11. Cecil KM, Lenkinski RE, Gur RE, et al: Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroIeptic naive patients with schizophrenia. Neuropsychopharmacology 1999; 20:131-140
12. Deicken R, Zhou L, Schuff N, et al: Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Biol Psychiatry 1998; 43:483-488
13. Kegeles LS, Humaran TJ, Mann JJ: In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy. Biol Psychiatry 1998; 44:382-398
14. Bertolino A, Callicott JH, Elman I, et al: Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 1998; 43:641-648
15. Braus DF, Ende G, Sartorius A, et al: Differential effects of typical versus atypical neuroleptics: an fMRI and MRSI study in schizophrenic patients (abstract). Proceedings of 6th Scientific Meeting, International Society for Magnetic Resonance in Medicine, 1998, p 1589
16. Heimberg C, Komoroski RA, Lawson WB, et al: Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect. Psychiatry Res (Neuroimaging) 1998; 83:105-115